Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Stomach Neoplasms 4Uterine Cervical Neoplasms 1Patient Compliance 1Pancreatic Neoplasms 1Head and Neck Neoplasms 1Fruquintinib 1Colorectal Neoplasms 1Carcinoma, Hepatocellular 1

Interventions

Cisplatin 44Paclitaxel 21Radiotherapy 20Brachytherapy 19Carboplatin 18Bevacizumab 7Drug Therapy 6camrelizumab 5toripalimab 4nimotuzumab 4Radiation 4Neoadjuvant Therapy 4Gemcitabine 4tislelizumab 3sintilimab 3pembrolizumab 3apatinib 3Vaccines 3TP protocol 3Surgical Procedures, Operative 3Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 3nedaplatin 2fludarabine 2endostar protein 2anlotinib 2Topotecan 2Surveys and Questionnaires 2Sentinel Lymph Node Biopsy 2Radiotherapy, Intensity-Modulated 2Mindfulness 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Uterine Cervical Neoplasms × potassium oxonate × Clear all
NCT04310774 2020-03-19

CCRT Followed by Tegafur, Gimeracil and Oteracil Potassium in Cervical Cancer

Peking Union Medical College Hospital

Phase 1/2 Unknown
200 enrolled
Gynecologic

Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡